Suppr超能文献

先天性膈疝患者单次与重复体外膜肺氧合运行的生存和神经发育结局。

Survival and Neurodevelopmental Outcomes in Congenital Diaphragmatic Hernia Patients with Single versus Repeat Extracorporeal Membrane Oxygenation Runs.

机构信息

Division of Neonatology, Department of Pediatrics, East Carolina University, Greenville, North Carolina.

Division of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.

出版信息

Am J Perinatol. 2024 May;41(S 01):e305-e311. doi: 10.1055/a-1877-9225. Epub 2022 Jun 16.

Abstract

OBJECTIVE

We describe the survival and neurodevelopmental outcomes of congenital diaphragmatic hernia (CDH) patients who received single and repeat extracorporeal membrane oxygenation (ECMO).

STUDY DESIGN

This is a retrospective single-center study comparing neurodevelopmental outcomes in CDH patients who were managed without ECMO, who received one ECMO run, and those who received two ECMO runs. Neurodevelopmental testing was performed utilizing the Bayley Scales of Infant Development-III.

RESULTS

There were 68 neonates identified with CDH from January 2011 to June 2019: 30 did not receive ECMO, 29 received single ECMO run, and 9 received two ECMO runs. Survival of ECMO patients was 50%, with 48% of single run and 57% of repeat run patients surviving to discharge. Second-run ECMO patients had increased median ventilator days (60 vs. 33,  = 0.04) and increased median length of hospital stay (159 vs. 89,  = 0.01). Neurodevelopmental testing via Bayley Scales of Infant Development-III was performed on 74% of survivors at the mean age of 24 months. CDH neonates who underwent ECMO (single or repeat runs) were more likely to have lower cognitive, language, and motor composite scores as compared with CDH neonates who had not required ECMO. Motor composite scores were significantly lower in repeat ECMO run neonates as compared with single ECMO run (72 + 6 vs. 85 + 4,  = 0.0003), but there were no further deficits noted in language or cognitive domains.

CONCLUSION

Survival after a second ECMO run in CDH is possible, although with increased ventilator days and increased length of hospitalization. We also find further deficits in motor outcomes in the second-run ECMO group compared with single-run ECMO. Our findings do not preclude a second ECMO run, but rather inform our counseling to families and reinforce the need for close neurodevelopmental follow-up for these patients.

KEY POINTS

· A repeat ECMO run is associated with further neurodevelopmental deficits in the motor domain.. · Survival is possible after repeat ECMO and is associated with increased length of hospital stay.. · Neurodevelopmental follow-up is critical for all CDH ECMO patients..

摘要

目的

我们描述了接受单次和重复体外膜肺氧合(ECMO)治疗的先天性膈疝(CDH)患者的生存和神经发育结局。

研究设计

这是一项回顾性单中心研究,比较了未接受 ECMO 治疗、接受单次 ECMO 运行和接受两次 ECMO 运行的 CDH 患者的神经发育结局。神经发育测试采用贝利婴幼儿发展量表第三版进行。

结果

2011 年 1 月至 2019 年 6 月期间,共有 68 例新生儿被诊断为 CDH:30 例未接受 ECMO 治疗,29 例接受单次 ECMO 运行,9 例接受两次 ECMO 运行。ECMO 患者的存活率为 50%,其中单次运行组的存活率为 48%,重复运行组的存活率为 57%。进行第二次 ECMO 的患者的中位呼吸机使用天数(60 比 33,=0.04)和中位住院时间(159 比 89,=0.01)均增加。通过贝利婴幼儿发展量表第三版对 74%的幸存者进行了神经发育测试,测试在平均 24 个月龄时进行。与未接受 ECMO 的 CDH 新生儿相比,接受 ECMO(单次或重复运行)的 CDH 新生儿更有可能出现较低的认知、语言和运动综合评分。与单次 ECMO 运行组相比,重复 ECMO 运行组的新生儿运动综合评分明显较低(72+6 比 85+4,=0.0003),但在语言或认知领域未发现进一步的缺陷。

结论

尽管第二次 ECMO 运行后需要更长的呼吸机使用时间和住院时间,但 CDH 患者再次接受 ECMO 运行是可能的。我们还发现,与单次 ECMO 运行组相比,第二次 ECMO 运行组的患儿在运动功能方面存在进一步的缺陷。我们的研究结果并不排除再次进行 ECMO 运行,但这确实会影响我们对患儿家属的咨询,并强调需要对这些患儿进行密切的神经发育随访。

关键点

·重复 ECMO 运行与运动领域的进一步神经发育缺陷有关。·重复 ECMO 运行后可存活,并与住院时间延长有关。·所有接受 ECMO 的 CDH 患儿均需要进行神经发育随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验